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ABSTRACT
Graham Little-Piccardi-Lassueur syndrome also called in a shorter form as Graham-Little syndrome, is a rare clinical entity characterized 
by the symptomatic triad including multifocal progressive cicatricial alopecia on the scalp, non-scarring hair loss of axillae and pubic 
areas and presence of keratosis pilaris-like eruption on the trunk and extremities. The etiology of the disease remains unknown with 
some hypotheses proposed. The condition is diagnosed based on clinical presentation, trichoscopical characteristic findings and histo-
pathological analysis. The treatment of the syndrome is challenging. The therapeutic strategy includes topical or systemic corticosteroids, 
retinoids and PUVA therapy with different efficacy. We present the case of this rare syndrome and discuss it from the practical point of 
view in terms of diagnosis and treatment approach. 
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INtRodUctIoN
Graham-Little syndrome (also known as Graham Little-
-Piccardi-Lassueur syndrome, GLS or GLPLS) is a rare subtype 
of lichen planopilaris characterized by the distinctive triad 
of symptoms, including coexistence of multifocal progres-
sive scarring alopecia on the scalp, non-scarring hair loss 
of axillar and inguinal areas and the presence of follicular 
skin lesions on the trunk and extremities with lichenoid 
vellus hairs inflammation histopathologically, called kera-
tosis spinulosa [1, 2]. Graham-Little syndrome is a chronic 
disease characterized by flare-ups and remissions leading 
to scalp permanent hair loss when left untreated. It more 
often affects white women in their early fifties [3]. 
caSe RePoRt 
61-year old woman was admitted to the outpatient 
clinic with a two year history of lichen planopilaris on her 
scalp with vertex and frontal involvement (Fig. 1). Her con-
comitant diseases included hypothyroidism due to subtotal 
strumectomy performed in the past and treated squamous 
cell dysplasia of the vulva. At the time of examination she 
presented with scarring hair loss of her scalp, complaining 
about severe itching and burning of this particular area of 
the skin showing inflammation and scaling of periauricular 
and occipital regions (Fig. 2). The presence of lichenoid, pig-
mented lesions of her armpits was also noticed (Fig. 3). The 
face and neck were covered with scattered palpable pinkish, 
inflamed, hyperkeratotic papules, previously also detected 
on her oral mucosa. Trichoscopy examination images per-
Figure 1. Scarring alopecia in the process of lichen planopilaris on 
the vertex and frontal region of the patient scalp
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Figure 2. The periauricular area of the patient scalp giving her itching 
and burning sensation with noticeable perifollicular inflammation 
around the hairs at the periphery of the scarred area
Figure 3. The armpit presented decreased hair density with brown 
red discoloration of the skin
Figure 4. Trichoscopic characteristic findings of the lichen 
planopilaris on the patient scalp included A. dystrophic hairs and 
irregular white dots coalescing into white or reddish areas of the skin 
(20×); B. perifollicular scaling (50×); and C. peripilar erythema with 
dilated blood vessels and milky red areas (50×)
A
B
C
formed by Fotofinder digital dermoscope at 20× and 50× 
fold magnification, either dry or with immersion fluid, re-
vealed the features of lichen planopilaris of the scalp with 
characteristic irregular white dots coalescing into white or 
reddish areas of the skin, dystrophic hairs and perifollicular 
scaling (Fig. 4 A–C). In her armpit, trichoscopy examination 
revealed non-scarring alopecia of the armpit (Fig. 5). 
Trichoscopy guided scalp biopsy of the involved lonely 
hair presented on Fig. 4C, revealed terminal hair with lichen-
oid lymphocytic infiltrate in its upper part with vacuolar 
degeneration of the hair epithelium, features of the scarring 
alopecia with loss of terminal and vellus hair follicles re-
placed by fibrous tracts, preserved arrector pili muscles with 
dilated blood vessels (Fig. 6, H and E, 40 × magnification). 
The biopsy from the involved armpit skin showed interface 
lichenoid inflammation of the epidermis with pigment in-
continence in the papillary dermis (Fig. 7A) coexisting with 
terminal hair affected by lichenoid lymphocytic infiltrate 
of the hair epithelium with lymphocytic exocytosis and 
dyskeratotic and necrotic keratinocytes in the epithelium 
leading to disturbed maturation of the inner root sheath 
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Figure 5. Trichoscopy of the armpit revealed sparse, thin and long 
hair shafts with faint yellow dots
Figure 6. The biopsy from the involved scalp with selected terminal 
hair presented on Fig. 4C revealed terminal hair with lichenoid 
lymphocytic infiltrate in its upper part with vacuolar degeneration 
of the hair epithelium, features of the scarring alopecia with loss of 
terminal and vellus hair follicles replaced by fibrous tracts, preserved 
arrector pili muscles with dilated blood vessels in reticular dermis (H 
and E, 40×)
Figure 7. The biopsy from the armpit showed interface lichenoid 
inflammation of the epidermis with pigment incontinence in the 
papillary dermis (A) and terminal hair with lichenoid lymphocytic 
infiltrate of the hair epithelium with lymphocytes exocytosis and 
dyskeratotic and necrotic keratinocytes in the epithelium leading to 
disturbed maturation of the inner root sheath (B)
A
B
(Fig. 7B). The patient was diagnosed with Graham-Little 
syndrome. 
The patient was implemented with oral acitretin 
10 mg/day, topical 0.1% tacrolimus ointment for her skin 
lesions and topical bethametasone in solution once per 
day for her sensation of itching and burning. She was also 
given three courses of intralesional injections with triam-
cinolone acetonide on her most severe and inflamed scalp 
lesions every six weeks. Her complaints resolved soon after 
combined treatment introduction, but scalp hairs regrowth 
was not obtained. The inflammatory pigmented plaques in 
the armpits resolved and follicular hyperkeratotic papules of 
the face and neck disappeared leaving normal looking skin. 
dIScUSSIoN
Graham-Little syndrome (GLS) was for the first time de-
scribed by Piccardi in 1914, and a year later by Ernst Graham-
-Little [2]. The origin of GLS has been elucidated with some 
hypotheses, but still remains unexplained. Most authors 
consider the condition as a form of lichen planopilaris, the 
subtype of lichen planus with hair involvement and destruc-
tion [3–6]. The development of the disease depends on the 
hair follicle condition, which at the beginning is filled with 
keratotic plug, then becomes surrounded by lymphocytic 
inflammatory infiltrate generating lichenoid-interface reac-
tion leading to epithelium destruction ending up with hair 
loss with concomitant scarring. Bardazzi et al. raised a hy-
pothesis of potential viral etiology since he described the 
development of both Graham-Little syndrome and lichen 
planus after hepatitis B virus (HBV) vaccination [7]. There 
are also reports suggesting a potential autoimmune con-
nection related to autoantibodies against INCENP protein, 
which is responsible for mitosis regulation and chromosome 
segregation [8] as well as familial predispositions to GLS con-
nected to HLA-DR1 (human leukocyte antigen) inheritance, 
according to Viglizzo et al., who described familial case of 
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Graham-Little syndrome in both mother and daughter [9]. 
The association with hormonal dysregulation, such as an-
drogen insensitivity syndrome, has also been reported [1].
This condition the most often affects middle-aged 
caucasian women in their perimenopausal age, but racial 
prevalence has not been confirmed. The syndrome usually 
develops slowly within months or years [10]. According to 
its hypothesized correlation with lichen planus, pruritus 
remains common but not constant feature among patients 
with GLS [9]. As mentioned before, the disease hallmark 
triad contains: i) multifocal cicatricial alopecia of the scalp, ii) 
hair decrement in the axillae and/or groins with no signs of 
scarring and also iii) presence of skin lesions typical for lichen 
planopilaris with vellus hairs involvement, which manifest 
as small disseminated keratotic reddish-brown acuminate 
or spinous follicular papules localized on the trunk or/and 
extremities, which can coalesce into larger plaques [2, 11]. 
The components of the triad do not have to occur simulta-
neously. However, non-scarring alopecia of the eyebrows 
and follicular papules of the face have also been reported 
as features of the syndrome [6]. Disease activity can be eva-
luated by the clinical hair examination and the positive pull 
test indicating the active stage of the process [12].
Trichoscopic findings of lichen planopilaris depend on 
the activity and severity of the disease. Active lesions are 
characterized by the presence of silver-white perifollicular, 
collar-like scaling (peripilar casts) around the hair shafts, 
protruding few millimeters above the skin surface (which 
is considered a hallmark of lichen planopilaris, especial-
ly observed with dry trichoscopy), as well as perifollicular 
inflammation, violaceous (blue-violet) areas surrounding 
empty hair follicles sometimes associated with pigment 
incontinence, elongated linear blood vessels, honeycomb 
pattern hyperpigmentation and tufted hairs (5 or more hairs 
growing out of the one hair opening). The interfollicular 
epidermis is usually spared in contrast to discoid lupus 
erythematosus, which is the main differential diagnosis for 
lichen planopilaris [11, 13, 14].
The inactive phase of lichen planopilaris is characterized 
by predominance of irregular white dots fusing into white 
or milky-red areas on the skin, which correlate with perifol-
licular fibrosis, characteristic for folliculocentric cicatricial 
alopecia. These features may occur in other examples of 
cicatricial alopecia, but also need a differentiation from 
eccrine gland excretory ducts visible on sun-exposed skin, 
which can visually mimic fibrotic white dots. Late stage of 
LPP may manifest by the presence of hair tufts containing 
between 5 up to 9 hairs.
Skin lesions detected in patients with Graham-Little 
syndrome show no difference in comparison to classic lichen 
planopilaris and result from body vellus hairs involvement 
and present as erythematous, rough follicular papules. The 
examination of pubic and axillary areas reveals hypopig-
mented, thin, degenerative terminal hairs without signs 
of fibrotic process such as white dots. Yellow dots can be 
present [15].
The target of inflammation and destruction in the hair 
epithelium is localized in the upper half of pilosebaceous 
unit, such as infundibulum and isthmus [16]. Histopatho-
logical examination reveals band-like, lichenoid inflamma-
tory lymphocytic infiltrate between follicular epithelium 
and the dermis. The absence of sebaceous glands is also 
noticeable, especially in the early onset of the disease [17]. 
The epithelium-directed lymphocytic exocytosis is also 
noticeable. Keratinocyte dyskeratosis varies in its severity 
(from mild to severe) and is localized usually next to the 
epithelial-dermal junction. Hair follicle orifices are usually 
affected by inflammation around infundibulum, which lead 
to hypergranulosis and hyperkeratosis inside infundibulum. 
Direct immunofluorescence of the involved tissue may show 
the deposits of globular IgM cytoid bodies in follicular epi-
thelium. Hypergranulosis, acanthosis, Civatte bodies and 
pigment incontinence may also be seen [18, 19].
The advanced stage of the disease manifests with con-
centric, lamellar fibroplasia or compact fibrosis around the 
openings of affected hair follicles leading finally to hair 
follicle contraction and decapitation. As the final result, 
the longitudinal scar so called fibrous tract, replacing pre-
existing hair follicle in the dermis is formed. Fusion of the 
follicles and inner root sheath degeneration can also be 
noticed. The specimens taken from axillary areas and groins 
show no signs of atrophy [3, 18, 19].
Differential diagnosis of Graham-Little syndrome should 
include other causes of cicatricial alopecia, such as disco-
id lupus erythematosus, pseudopelade of Brocq, frontal 
fibrosing alopecia, pityriasis rubra pilaris, sarcoidosis, fol-
licular mucinosis, folliculitis decalvans or keratosis pilaris 
atrophicans [7, 12]. In ambiguous cases with inconclusive 
trichoscopical findings, the trichoscopy guided biopsy is 
recommended for histopathological evaluation. 
Treatment of Graham-Little syndrome includes topical, 
intralesional or systemic corticosteroids with different effi-
cacy [3, 6], topical tacrolimus, retinoids or PUVA therapy, but 
some cases prove cyclosporine A effectiveness, as an exam-
ple of drug succeeding in hair growth induction and the 
hypothesis has been stated, that it could be administered 
in early stage of the condition, before the fibrosis develops 
[20]. Hydroxychloroquine has been reported as an useful 
drug in lichen planopilaris and frontal fibrosing alopecia 
cases, resulting in decreasing the signs and symptoms of 
the disease, according to LPPAI (Lichen Planopilaris Acti-
vity Index) [21], but we do not share this observation. In 
our hands the administration of systemic retinoids, such as 
isotretinoin and acitretin is beneficial for the stabilization 
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of lichen planopilaris type such as frontal fibrosing alopecia 
[22], therefore small dose of acitretin was introduced to our 
patient with Graham-Little syndrome with a good tolerance 
and clinical efficacy. The presence of progressive fibrosis and 
concomitant inflammation is responsible for the complex 
and challenging treatment of the disease [2, 3]. The choice 
and duration of the therapy is guided by the response and 
relapse rate of Graham-Little entity. 
coNclUSIoNS
Graham-Little syndrome is relatively rare, distinctive 
disorder requesting a consideration while differentiating 
common cicatricial alopecia entities. Early diagnosis of 
subtle lesions of GLS followed by adequate treatment may 
prevent patients from permanent hair scalp alopecia and 
disease progression. The condition has a chronic course. The 
advanced stage of the disease has a noticeable esthetic im-
pact on the patient life. Thorough examination of the scalp 
and hormone-dependent body areas with the knowledge of 
the characteristic hair-loss patterns and lichenoid follicular 
skin eruptions with well described trichoscopical findings 
[23] are crucial to make the diagnosis of Graham-Little syn-
drome, entity described over 100 years ago. 
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